Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 0.00 is 100% below its 1-year average of 0.02, near the low end of its 1-year range (0.00–0.04).
As of 2026-10-06T15:06:31.004Z.
Calculation as of: 2026-10-06T15:06:31.004Z.
Quote observation: 2026-10-06T15:05:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16b0ce149acf027305ec47ed69e441f7c4eae43bc3095c7aeda967d53938ba16
PE RATIO
0.00
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.36
median of 160 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$5.68M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.43M
PE Ratio
N/A
TTM Avg
4788.36
3Y Avg
147312.95
5Y Avg
148989.26
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. (ENLV) | $5.99M | 0.00 | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.17M | N/A | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.81M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.27M | N/A | 278.25 | 163.06 | 336.05 |
| enVVeno Medical Corporation (NVNO)vs › | $5.84M | N/A | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.68M | N/A | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.57M | N/A | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | N/A | 4788.36 | 147312.95 | 148989.26 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | N/A | N/A | N/A | N/A |
At 0.0, P/E is below its 1-year median — higher than 0% of readings in its 1-year history.
1-year low
0.0
median
0.0
1-year high
0.0
Trailing P/E
0.0
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.36
Forward EPS (Est.)
$-1.15
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 0.00 |
| 2026-10-02 | 0.00 |
| 2026-10-01 | 0.00 |
| 2026-09-30 | 0.00 |
| 2026-09-29 | 0.00 |
| 2026-09-28 | 0.00 |
| 2026-09-25 | 0.00 |
| 2026-09-24 | 0.00 |
| 2026-09-23 | 0.00 |
| 2026-09-22 | 0.00 |
| 2026-09-21 | 0.00 |
| 2026-09-18 | 0.00 |
| 2026-09-17 | 0.00 |
| 2026-09-16 | 0.00 |
| 2026-09-15 | 0.00 |
| 2026-09-14 | 0.00 |
| 2026-09-11 | 0.00 |
| 2026-09-10 | 0.00 |
| 2026-09-09 | 0.00 |
| 2026-09-08 | 0.00 |
| 2026-09-04 | 0.00 |
| 2026-09-03 | 0.00 |
| 2026-09-02 | 0.00 |
| 2026-09-01 | 0.00 |
| 2026-08-31 | 0.00 |
| 2026-08-28 | 0.00 |
| 2026-08-27 | 0.00 |
| 2026-08-26 | 0.00 |
| 2026-08-25 | 0.00 |
| 2026-08-24 | 0.00 |
| 2026-08-21 | 0.00 |
| 2026-08-20 | 0.00 |
| 2026-08-19 | 0.00 |
| 2026-08-18 | 0.00 |
| 2026-08-17 | 0.00 |
| 2026-08-14 | 0.00 |
| 2026-08-13 | 0.00 |
| 2026-08-12 | 0.00 |
| 2026-08-11 | 0.00 |
| 2026-08-10 | 0.00 |
| 2026-08-07 | 0.00 |
| 2026-08-06 | 0.00 |
| 2026-08-05 | 0.00 |
| 2026-08-04 | 0.00 |
| 2026-08-03 | 0.00 |
| 2026-07-31 | 0.00 |
| 2026-07-30 | 0.00 |
| 2026-07-29 | 0.01 |
| 2026-07-28 | 0.01 |
| 2026-07-27 | 0.01 |
| 2026-07-24 | 0.01 |
| 2026-07-23 | 0.01 |
| 2026-07-22 | 0.01 |
| 2026-07-21 | 0.01 |
| 2026-07-20 | 0.01 |
| 2026-07-17 | 0.01 |
| 2026-07-16 | 0.01 |
| 2026-07-15 | 0.01 |
| 2026-07-14 | 0.01 |
| 2026-07-13 | 0.02 |
| 2026-07-10 | 0.02 |
| 2026-07-09 | 0.02 |
| 2026-07-08 | 0.02 |
| 2026-07-07 | 0.02 |
| 2026-07-06 | 0.02 |
| 2026-07-02 | 0.02 |
| 2026-07-01 | 0.02 |
| 2026-06-30 | 0.02 |
| 2026-06-29 | 0.02 |
| 2026-06-26 | 0.02 |
| 2026-06-25 | 0.02 |
| 2026-06-24 | 0.02 |
| 2026-06-23 | 0.02 |
| 2026-06-22 | 0.02 |
| 2026-06-18 | 0.02 |
| 2026-06-17 | 0.02 |
| 2026-06-16 | 0.02 |
| 2026-06-15 | 0.02 |
| 2026-06-12 | 0.02 |
| 2026-06-11 | 0.02 |
| 2026-06-10 | 0.02 |
| 2026-06-09 | 0.02 |
| 2026-06-08 | 0.02 |
| 2026-06-05 | 0.02 |
| 2026-06-04 | 0.03 |
| 2026-06-03 | 0.03 |
| 2026-06-02 | 0.03 |
| 2026-06-01 | 0.03 |
| 2026-05-29 | 0.03 |
| 2026-05-28 | 0.03 |
| 2026-05-27 | 0.03 |
| 2026-05-26 | 0.02 |
| 2026-05-22 | 0.02 |
| 2026-05-21 | 0.02 |
| 2026-05-20 | 0.02 |
| 2026-05-19 | 0.02 |
| 2026-05-18 | 0.02 |
| 2026-05-15 | 0.02 |
| 2026-05-14 | 0.03 |
| 2026-05-13 | 0.03 |
| 2026-05-12 | 0.03 |
| 2026-05-11 | 0.03 |
| 2026-05-08 | 0.03 |
| 2026-05-07 | 0.03 |
| 2026-05-06 | 0.03 |
| 2026-05-05 | 0.03 |
| 2026-05-04 | 0.03 |
| 2026-05-01 | 0.03 |
| 2026-04-30 | 0.03 |
| 2026-04-29 | 0.03 |
| 2026-04-28 | 0.03 |
| 2026-04-27 | 0.03 |
| 2026-04-24 | 0.03 |
| 2026-04-23 | 0.03 |
| 2026-04-22 | 0.03 |
| 2026-04-21 | 0.03 |
| 2026-04-20 | 0.03 |
| 2026-04-17 | 0.03 |
| 2026-04-16 | 0.03 |
| 2026-04-15 | 0.03 |
| 2026-04-14 | 0.03 |
| 2026-04-13 | 0.03 |
| 2026-04-10 | 0.03 |
| 2026-04-09 | 0.03 |
| 2026-04-08 | 0.03 |
| 2026-04-07 | 0.03 |
| 2026-04-06 | 0.03 |
| 2026-04-02 | 0.03 |
| 2026-04-01 | 0.03 |
| 2026-03-31 | 0.04 |
| 2026-03-30 | 0.04 |
| 2026-03-27 | 0.04 |
| 2026-03-26 | 0.04 |
